Co-infection of influenza virus and SARS-CoV-2 can lead to more severe disease than infection of either alone.

If the recommendation is accepted by the European Commission, Moderna's mCombriax vaccine will be available for adults 50 and older throughout the European Union.

France has reported its first cases of the potentially fatal Middle East Respiratory Syndrome (MERS) in over a decade, sparking concerns about emerging infectious diseases across a continent still ...

While the FDA has flip-flopped on whether to review Moderna’s combination influenza and COVID-19 vaccine, it’s full speed ahead for the mRNA shot in Europe. | While the FDA has flip-flopped on whether ...

A groundbreaking study explains why certain COVID-19 vaccines caused dangerous blood clots, hemorrhages and VITT syndrome, ...